FRANCISCO JAVIER
MENÁRGUEZ PALANCA
Profesor asociado de Ciencias de la Salud
Fundación Jiménez Díaz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (10)
2020
-
Lymphoplasmacytic lymphoma associated with diffuse large B-cell lymphoma: Progression or divergent evolution?
PLoS ONE, Vol. 15, Núm. 11 November
2018
2017
-
Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets
Oncotarget, Vol. 8, Núm. 67, pp. 111386-111395
2014
-
Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: A clinicopathological study
Modern Pathology, Vol. 27, Núm. 2, pp. 281-293
-
The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature
Blood
2013
-
Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas
Blood Cancer Journal, Vol. 3, Núm. 4
-
MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma
British Journal of Haematology, Vol. 162, Núm. 3, pp. 336-347
-
Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas
Haematologica, Vol. 98, Núm. 1, pp. 57-64
2010
-
Amolecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma
Blood, Vol. 116, Núm. 8
1996
-
Evaluation of the international index in the prognosis of high grade gastric malt lymphoma
Leukemia and Lymphoma, Vol. 24, Núm. 1-2, pp. 159-163